SwePub
Sök i LIBRIS databas

  Utökad sökning

swepub
 

Sökning: swepub > Management and outc...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00007424naa a2200805 4500
001oai:DiVA.org:oru-77694
003SwePub
008191031s2019 | |||||||||||000 ||eng|
009oai:DiVA.org:umu-165088
009oai:prod.swepub.kib.ki.se:231663405
009oai:prod.swepub.kib.ki.se:142186667
009oai:DiVA.org:liu-162068
009oai:lup.lub.lu.se:799c1672-08bb-43f1-926a-24bca5eedc74
009oai:gup.ub.gu.se/285806
024a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-776942 URI
024a https://doi.org/10.1080/21681805.2019.16815042 DOI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1650882 URI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:2316634052 URI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1421866672 URI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1620682 URI
024a https://lup.lub.lu.se/record/799c1672-08bb-43f1-926a-24bca5eedc742 URI
024a https://gup.ub.gu.se/publication/2858062 URI
040 a (SwePub)orud (SwePub)umud (SwePub)kid (SwePub)kid (SwePub)liud (SwePub)lud (SwePub)gu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Abdul-Sattar Aljabery, Firasu Linköping University,Linköpings universitet,Institutionen för klinisk och experimentell medicin,Medicinska fakulteten,Region Östergötland, Urologiska kliniken i Östergötland4 aut0 (Swepub:liu)firab05
2451 0a Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe)
264 c 2019-10-30
264 1b Informa Healthcare,c 2019
338 a print2 rdacarrier
500 a Funding Agencies|Swedish Cancer SocietySwedish Cancer Society [CAN 2016/470, CAN 2017/278]
520 a Purpose: To investigate the clinical management and outcome of patients with muscle-invasive bladder cancer with clinical lymph node involvement, using longitudinal nationwide population-based data.Methods: In the Bladder Cancer Data Base Sweden (BladderBaSe), treatment and survival in patients with urinary bladder cancer clinical stage T2-T4 N + M0 diagnosed between 1997 and 2014 was investigated. Patients´ characteristics were studied in relation to TNM classification, curative or palliative treatment, cancer-specific (CSS) and overall survival (OS). Age at diagnosis was categorised as ≤60, 61-70, 71-80 and >80 years, and time periods were stratified as follows: 1997-2001, 2002-2005, 2006-2010 and 2011-2014.Results: There were 786 patients (72% males) with a median age of 71 years (interquartile range = 64-79 years). The proportion of patients with high comorbidity increased over time. Despite similar low comorbidity, curative treatment was given to 44% and to 70% of those in older (>70 years) and younger age groups, respectively. Curative treatment decreased over time, but chemotherapy and cystectomy increased to 25% during the last time period. Patients with curative treatment had better survival compared to those with palliative treatment, both regarding CSS and OS in the whole cohort and in all age groups.Conclusions: The low proportion of older patients undergoing treatment with curative intent, despite no or limited comorbidity, indicates missed chances of treatment with curative intent. The reasons for an overall decrease in curative treatment over time need to be analysed and the challenge of coping with an increasing proportion of node-positive patients with clinically significant comorbidity needs to be met.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
653 a Bladder cancer
653 a cohort study
653 a lymph node metastasis
653 a management
653 a outcome
653 a Bladder cancer
653 a cohort study
653 a lymph node metastasis
653 a management
653 a outcome
700a Liedberg, Fredriku Lund University,Lunds universitet,Urologi - blåscancer, Malmö,Forskargrupper vid Lunds universitet,Urology - urothelial cancer, Malmö,Lund University Research Groups,Skåne University Hospital4 aut0 (Swepub:lu)urok-fli
700a Häggström, Christelu Uppsala University,Umeå University,Umeå universitet,Enheten för biobanksforskning,Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Department of Biobank Research, Umeå University, Umeå, Sweden,Uppsala Univ, Sweden; Umea Univ, Sweden4 aut0 (Swepub:umu)chlham02
700a Ströck, Vivekau Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology4 aut0 (Swepub:gu)xstrvi
700a Hosseini, Abolfazlu Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden,Karolinska Univ Hosp, Sweden4 aut
700a Gårdmark, Trulsu Karolinska Institutet,Karolinska Inst, Sweden,Danderyd Hospital4 aut
700a Sherif, Amiru Umeå University,Umeå universitet,Urologi och andrologi,Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden,Umea Univ, Sweden4 aut0 (Swepub:umu)amsh0008
700a Jerlström, Tomas,d 1969-u Örebro University,Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Urology,Orebro Univ, Sweden4 aut0 (Swepub:oru)tjm
700a Malmström, Per-Unou Uppsala University4 aut
700a Holmberg, Larsu Uppsala University,King's College London4 aut
700a Hagberg, Oskaru Lund University,Lunds universitet,Urologi - blåscancer, Malmö,Forskargrupper vid Lunds universitet,Urology - urothelial cancer, Malmö,Lund University Research Groups4 aut0 (Swepub:lu)mats-oha
700a Jahnson, Staffanu Linköping University,Linköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Urologiska kliniken i Östergötland4 aut0 (Swepub:liu)staja74
710a Linköpings universitetb Institutionen för klinisk och experimentell medicin4 org
773t Scandinavian journal of urologyd : Informa Healthcareg 53:5, s. 332-338q 53:5<332-338x 2168-1805x 2168-1813
856u http://dx.doi.org/10.1080/21681805.2019.1681504y FULLTEXT
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-77694
8564 8u https://doi.org/10.1080/21681805.2019.1681504
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165088
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:231663405
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:142186667
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-162068
8564 8u https://lup.lub.lu.se/record/799c1672-08bb-43f1-926a-24bca5eedc74
8564 8u https://gup.ub.gu.se/publication/285806

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy